Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 11.02%2.61B | 12.31%1.73B | 9.98%728.36M | 3.72%3.2B | -0.28%2.35B | -2.88%1.54B | -9.50%662.3M | -0.36%3.09B | -2.25%2.36B | 3.58%1.58B |
| Refunds of taxes and levies | -16.31%37.34M | -0.11%26.11M | 31.21%17.32M | 2.24%53.55M | 13.14%44.62M | -7.93%26.14M | 5.43%13.2M | 9.02%52.38M | 13.87%39.44M | 42.00%28.39M |
| Cash received relating to other operating activities | 28.19%56.58M | 90.93%34.59M | -21.38%17.9M | 3.42%52.38M | 39.33%44.14M | 68.74%18.12M | -22.44%22.77M | 52.09%50.65M | -68.45%31.68M | -81.65%10.74M |
| Cash inflows from operating activities | 10.83%2.7B | 13.00%1.79B | 9.35%763.58M | 3.69%3.31B | 0.46%2.44B | -2.49%1.58B | -9.75%698.27M | 0.33%3.19B | -4.65%2.43B | 0.96%1.62B |
| Goods services cash paid | 2.00%1.45B | -0.35%943.26M | -10.89%382.73M | 15.63%1.83B | 16.42%1.42B | 30.40%946.6M | 28.31%429.47M | 2.35%1.59B | -11.80%1.22B | -13.46%725.92M |
| Staff behalf paid | 8.57%379.65M | 7.92%251.62M | 10.16%160.7M | 0.69%442.81M | 4.32%349.67M | -3.21%233.15M | 4.31%145.88M | 1.54%439.77M | -4.79%335.19M | -6.01%240.87M |
| All taxes paid | -30.88%66.13M | -23.34%55.83M | -64.50%13.45M | 20.46%109.67M | 51.43%95.67M | 66.37%72.82M | 201.52%37.88M | -30.81%91.04M | -31.92%63.18M | -23.46%43.77M |
| Cash paid relating to other operating activities | 4.39%306.66M | 10.87%209.65M | 20.48%97.69M | -3.45%399.44M | 0.93%293.77M | 11.32%189.1M | 58.56%81.08M | 12.03%413.7M | 0.19%291.08M | -9.36%169.87M |
| Cash outflows from operating activities | 1.93%2.2B | 1.30%1.46B | -5.73%654.56M | 10.09%2.79B | 13.09%2.16B | 22.13%1.44B | 28.99%694.32M | 1.89%2.53B | -9.87%1.91B | -11.89%1.18B |
| Net cash flows from operating activities | 79.17%503.14M | 133.48%327.11M | 2,660.07%109.02M | -20.88%521.14M | -45.93%280.82M | -68.29%140.1M | -98.32%3.95M | -5.25%658.65M | 21.12%519.4M | 65.42%441.78M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 398.17%9.32M | ---- | ---- | 1,459.36%1.87M | 1,459.36%1.87M | ---- | ---- | -99.16%120K | -98.87%120K | -98.87%120K |
| Cash received from returns on investments | 331.58%21.26M | 242.69%12.01M | 213.78%3.87M | 52.40%8.92M | 20.76%4.93M | 2.75%3.51M | 59.02%1.23M | 94.08%5.85M | 199.80%4.08M | 207.53%3.41M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -52.93%1.62M | -77.71%538.12K | -81.44%130.63K | 36.12%4.8M | 18.42%3.45M | -23.56%2.41M | -35.68%703.93K | 7.06%3.53M | 85.58%2.91M | 177.61%3.16M |
| Cash received relating to other investing activities | 76.87%148.12M | 384.72%148.12M | 32.24%40.41M | -71.00%154.7M | -84.21%83.74M | -74.33%30.56M | -10.12%30.56M | 7.55%533.5M | 85.76%530.35M | -32.54%119.06M |
| Cash inflows from investing activities | 91.86%180.32M | 340.47%160.67M | 36.67%44.41M | -68.64%170.28M | -82.51%93.99M | -70.99%36.48M | -9.71%32.5M | 5.10%542.99M | 79.72%537.46M | -33.59%125.75M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -30.46%155.31M | -8.10%111.48M | 31.46%64.66M | 44.80%364.6M | 14.67%223.34M | 11.06%121.32M | -16.97%49.19M | 55.72%251.79M | 45.79%194.77M | 36.20%109.23M |
| Cash paid to acquire investments | -91.16%10.84M | -92.38%9.34M | -37.82%7.5M | ---- | 2,163.73%122.58M | 3,822.59%122.58M | 531.49%12.06M | -28.66%5.42M | -78.34%5.42M | --3.13M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | --122.95M | ---- | ---- | ---- | ---- | ---- | --0 |
| Cash paid relating to other investing activities | --321.8M | --31.8M | --30M | ---- | ---- | ---- | ---- | 24.55%732.95M | 66.40%641.47M | 178.35%491.29M |
| Cash outflows from investing activities | 41.06%487.95M | -37.42%152.63M | 66.80%102.16M | -50.76%487.55M | -58.90%345.92M | -59.60%243.9M | -44.90%61.25M | 30.66%990.15M | 54.69%841.66M | 135.15%603.65M |
| Net cash flows from investing activities | -22.11%-307.63M | 103.88%8.04M | -100.86%-57.75M | 29.05%-317.26M | 17.18%-251.94M | 56.60%-207.42M | 61.75%-28.75M | -85.43%-447.16M | -24.14%-304.19M | -609.73%-477.89M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | 7,512.62%113.93M | 592.97%10.37M | --4.32M | 1,548.52%15.17M | 62.68%1.5M | 62.68%1.5M | ---- | -44.24%920K | -44.24%920K | -44.24%920K |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | 7,512.62%113.93M | 592.97%10.37M | --4.32M | 1,548.52%15.17M | --1.5M | --1.5M | ---- | -44.24%920K | ---- | --0 |
| Cash from borrowing | 299.70%2.17B | 158.74%875.42M | 156.47%474.05M | 54.20%737.84M | 24.22%542.04M | -12.99%338.34M | -25.81%184.84M | -1.00%478.49M | 1.89%436.35M | 12.14%388.85M |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --117M | --117M | ---- |
| Cash inflows from financing activities | 319.56%2.28B | 160.65%885.79M | 158.80%478.37M | 26.26%753.01M | -1.94%543.54M | -12.81%339.84M | -25.81%184.84M | 22.98%596.41M | 28.93%554.27M | 11.87%389.77M |
| Borrowing repayment | 280.30%519.06M | 391.99%438.66M | 1,759.36%211.97M | -63.34%209.25M | -76.07%136.49M | -30.84%89.16M | -90.89%11.4M | 3.20%570.77M | 83.69%570.4M | -53.79%128.91M |
| Dividend interest payment | 97.04%285.43M | 97.23%260.99M | 119.99%10.54M | -8.59%145.74M | -11.29%144.86M | -11.04%132.32M | -66.63%4.79M | -60.41%159.44M | -59.23%163.3M | -61.58%148.75M |
| -Including:Cash payments for dividends or profit to minority shareholders | --578.54K | --290.34K | ---- | ---- | ---- | ---- | ---- | --285.38K | --286.24K | ---- |
| Cash payments relating to other financing activities | -7.08%35.6M | -5.56%23.22M | -2.54%12.53M | 2.26%52.54M | 9.01%38.32M | -5.86%24.58M | -3.38%12.85M | -37.72%51.38M | -50.42%35.15M | -55.48%26.11M |
| Cash outflows from financing activities | 162.80%840.09M | 193.77%722.86M | 709.30%235.03M | -47.86%407.53M | -58.42%319.66M | -19.00%246.07M | -80.99%29.04M | -24.72%781.59M | -1.68%768.86M | -58.09%303.77M |
| Net cash flows from financing activities | 543.40%1.44B | 73.75%162.93M | 56.19%243.34M | 286.56%345.48M | 204.33%223.87M | 9.04%93.77M | 61.69%155.8M | 66.53%-185.18M | 39.05%-214.59M | 122.85%86M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -396.71%-4.09M | -102.76%-205.42K | -159.20%-472.84K | -57.50%11.72M | -94.91%1.38M | -60.91%7.44M | 111.26%798.67K | 113.42%27.59M | 83.99%27.07M | -21.21%19.02M |
| Net increase in cash and cash equivalents | 542.12%1.63B | 1,369.02%497.88M | 123.18%294.14M | 940.93%561.08M | 817.76%254.13M | -50.81%33.89M | -47.18%131.8M | 162.37%53.9M | 118.03%27.69M | 145.17%68.9M |
| Add:Begin period cash and cash equivalents | 92.73%1.17B | 92.73%1.17B | 92.73%1.17B | 9.78%605.08M | 9.78%605.08M | 9.78%605.08M | 9.78%605.08M | -13.55%551.18M | -13.55%551.18M | -13.55%551.18M |
| End period cash equivalent | 225.65%2.8B | 160.42%1.66B | 98.17%1.46B | 92.73%1.17B | 48.43%859.21M | 3.05%638.97M | -7.97%736.88M | 9.78%605.08M | 19.60%578.87M | 27.83%620.08M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.